Department of Radiation Oncology.
Department of Orthopedics, Kaohsiung Veterans General Hospital, Kaohsiung.
Medicine (Baltimore). 2021 Mar 26;100(12):e23794. doi: 10.1097/MD.0000000000023794.
Diffuse pigmented villonodular synovitis (PVNS) of knee is a rare benign disease that has a destructive clinical course. Synovectomy and adjuvant radiotherapy (RT) have been reported as treatment options but literatures reporting functional outcomes were sparse. This study aimed to evaluate the long-term functional outcomes and disease control among treatment modalities through the 22 years of experience.A single-center database was searched for patients who received synovectomy of knee with the pathologic diagnosis of PVNS. General data, treatment modalities, and recurrent status were retrospectively collected from medical records. Functional outcomes were evaluated by Western Ontario and McMaster Universities Osteoarthritis Index through phone interviews by an independent orthopedist.From January 1995 to December 2017, 24 patients with diffuse PVNS of knee were identified, including 19 receiving open synovectomy (OP) and 5 undergoing arthroscopic surgery. Adjuvant RT was performed on 14 patients with a median dose of 35 Gy (range 20-40 Gy). After median follow up of 6 years, recurrences were recorded in 10 cases. The recurrence rate was significantly lower in the OP + RT group than the OP group (8.3% vs 57.1%, P = .038). Among those with preserved knee joints, there was no significant difference in the Western Ontario and McMaster Universities Osteoarthritis Index score and stiffness score between patients in the OP + RT and OP groups.For patients with diffuse PVNS of knee, the addition of moderate-dose adjuvant RT following OP provided excellent local control while maintaining good joint function with limited treatment-related morbidity. Our study emphasized the importance of moderate dose RT in diffuse PVNS of knee joint.
弥漫性色素绒毛结节性滑膜炎(PVNS)是一种罕见的良性疾病,具有破坏性的临床病程。滑膜切除术和辅助放疗(RT)已被报道为治疗选择,但报告功能结果的文献很少。本研究旨在通过 22 年的经验,评估治疗方式的长期功能结果和疾病控制。
从病历中回顾性收集了接受膝关节滑膜切除术且病理诊断为 PVNS 的患者的一般资料、治疗方式和复发情况。通过独立骨科医生的电话访谈,使用 Western Ontario 和 McMaster 大学骨关节炎指数评估功能结果。
从 1995 年 1 月至 2017 年 12 月,共确定了 24 例膝关节弥漫性 PVNS 患者,其中 19 例行开放性滑膜切除术(OP),5 例行关节镜手术。14 例患者接受辅助 RT,中位剂量为 35 Gy(范围 20-40 Gy)。中位随访 6 年后,记录到 10 例复发。OP+RT 组的复发率明显低于 OP 组(8.3% vs. 57.1%,P=0.038)。在保留膝关节的患者中,OP+RT 组和 OP 组的 Western Ontario 和 McMaster 大学骨关节炎指数评分和僵硬评分无显著差异。
对于膝关节弥漫性 PVNS 的患者,OP 后给予中剂量辅助 RT 可提供极好的局部控制,同时保持良好的关节功能,治疗相关发病率有限。我们的研究强调了中剂量 RT 在膝关节弥漫性 PVNS 中的重要性。